• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

PRESSLED

Your Leading News Source

PRESSLED
Your Leading News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • US
  • Meet the Reporters
  • About/Contact

Digital therapeutic for postpartum depression granted FDA Breakthrough Device Designation – Med-Tech Innovation

May 28, 2021 by Staff Reporter

Woebot Heath, a developer of relational technologies and tools to support mental health, has been granted U.S. Food and Drug Administration (FDA) Breakthrough Device Designation to the company’s digital therapeutic for the treatment of postpartum depression (PPD). 

WB001 is an investigational digital therapeutic, delivered over eight weeks via a patient’s smartphone, that combines cognitive behavioural therapy (CBT) and elements of interpersonal psychotherapy (IPT) with a deep understanding of the lived experience of PPD to reduce symptoms of depression. Intended as a prescription-only treatment to be used under the supervision of a clinician, WB001 also features the company’s relational agent Woebot, which was shown in a recent study to be capable of forming a bond with patients to support meaningful engagement and, potentially, better outcomes.

The FDA Breakthrough Device Program is intended to help patients receive more timely access to technologies that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions. FDA’s grant of breakthrough designation will allow Woebot Health to interact with FDA through several different program options to efficiently address topics as they arise during the pre-market review phase, receive feedback from the FDA, identify areas of agreement in a timely way and receive priority review of its marketing submission.

PPD is a major depressive episode with symptom onset during pregnancy or within four weeks of delivery. As many as 20% of women who have given birth experience PPD which, when left untreated, can present immediate and long-term risk to the mother and infant. Despite the prevalence and risks of PPD, almost 60% of women who experience PPD symptoms do not receive a clinical diagnosis. Among those who do screen positive for the condition, less than 25% receive follow-up care. 

Woebot Health’s chief clinical officer Athena Robinson, Ph.D, said: “The odds are truly stacked against women who are hit with barriers to treatment right after childbirth, especially those of lower socioeconomic status and/or minority populations who are at a higher risk for PPD but face ongoing and concerning care disparities that pervade the mental healthcare system. WB001 is designed to significantly reduce barriers to PPD care that often thwart help-seeking and treatment engagement behaviours—including lack of time, childcare issues, stigma and fear of loss of parental rights. We’re proud to be offering a scalable, clinically-validated digital treatment for such a pervasive, serious and heart-breaking condition.”

Proprietary research conducted with postpartum adults and clinicians at the onset of WB001’s development informed the treatment’s engagement and relational characteristics, which include targeted topic areas, empathy, normalisation, and clinical memory. Designed with the nuance of the PPD experience in mind and combining the active elements of proven therapeutic approaches delivered by a relational agent, WB001 is designed to increase patient motivation and treatment efficacy in a non-invasive way.

Decades of published research support CBT and IPT in the treatment of depression including PPD specifically; CBT and IPT are recommended by the American Psychiatric Association (APA), American College of Obstetricians and Gynaecologists (ACOG), United States Preventive Services Task Force (USPSTF) and the National Institute for Health and Care Excellence (NICE) for the treatment of PPD. WB001’s content includes psychoeducational lessons and CBT- or IPT-specific tools. The lessons teach PPD-specific information to normalise and contextualise postpartum experiences, as well as provide mood management and mental health promotion. The CBT-based tools guide patients through behavioural practices such as thought challenging, behavioural activation, mindfulness and self-care, while the IPT-based tools address relationship transitions, communication analysis and skill building, as well as role/identity changes.

>>>ad: Don't Miss TODAY'S BEST Amazon Deals!

Originally Appeared Here

Filed Under: TECH/SCIENCE

Primary Sidebar

More to See

Former Georgia Tech Kicker Harrison Butker Sends Kansas City To The Super Bowl

Harrison Butker is going to be playing for another Super Bowl with the Kansas City Chiefs.Butker nailed the game-winning field goal to send the Chiefs … [Read More...] about Former Georgia Tech Kicker Harrison Butker Sends Kansas City To The Super Bowl

Stock Market Opening News Today

Sensex, Nifty Open: आज अडानी ग्रुप शेयरों में बिकवाली जारी है. वहीं बैंक और फाइनेंशियल सेक्‍टर के हैवीवेट शेयरों ने भी बाजार को कमजोर किया है. Sensex, … [Read More...] about Stock Market Opening News Today

Henry Bott Now President of Swire Properties US

One of Hong Kong’s best known conglomerates leads this week’s set of personnel updates on Mingtiandi as Hong Kong’s John Swire and Sons announces new … [Read More...] about Henry Bott Now President of Swire Properties US

Privacy Policy | Terms and Conditions | About/ Contact
Copyright © 2023 · PRESSLED · As Amazon Associates we earn commissions from qualifying purchases · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT